Skip to main content

Haemokinesis Limited Class Pend

$0.20

This is the expected IPO issue price for HKX on 8 April 2022.
Register to track HKX and receive email alerts.

[ARTICLE] Blood testing biz Haemokinesis in $17m IPO

...

MediaBot

A news article has been posted about Haemokinesis Limited on the AFR. The article was published around , on 2 March 2022 at 12:27pm.

Haemokinesis’s board includes ASX-listed wealth platform Praemium’s former managing director Michael Ohanessian and Pacific Smiles Group founder Alex Abrahams.

Read Article
Recent Articles about ASX:HKX
19-Dec Blood Grouping Reagents Market Size &Amp; Analysis Report 2024-2031 | 113 Pages Report

menafn.com
23-Oct Sonic Healthcare Ltd (ASX: SHL) Share Price and News

fool.com.au
20-Sep Gabapentin Market Size, Unlocking Growth Potential and Share Projections for 2023-2030

linkedin.com
18-Sep Blood Group Test Cards Market 2023 | Important Elements, Scope and Segmentations by 2030

benzinga.com
8-Sep Blood-Grouping Reagents Market to grow by USD 456.95 million from 2022 to 2027, North America to account for 46% of market growth- Technavio

lelezard.com
19-Aug CIO Partners, Inc.’s Post

linkedin.com
19-Aug Hospital cyber attack linked to Rhysida, a newly formed gang that also hit the Chilean Army

hartfordbusiness.com
10-May Monash awarded more than $3.4M in ARC Early Career Industry Fellowships

monash.edu
5-May Blood Group Test Cards Market Getting Back To Stellar Growth Ahead : InTec,Diagast SAS, Haemokinesis

linkedin.com
24-Apr World-first app helps shift workers get more and better sleep

monash.edu
Tracked

Find all articles about Haemokinesis Limited, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

Register to track HKX and receive email alerts.